Drugs / hVEGF-A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00110500 | Apr 2005 → Jan 2008 | diabetic neuropathy | Sangamo Therapeutics | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hVEGF-A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00110500 ↗ |